tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IONS Stock Latest News

Nike upgraded, Sportradar initiated: Wall Street’s top analyst calls
The FlyNike upgraded, Sportradar initiated: Wall Street’s top analyst calls
13d ago
H
SG
Ionis Pharmaceuticals upgraded to Overweight from Equal Weight at Barclays
PremiumThe Fly
Ionis Pharmaceuticals upgraded to Overweight from Equal Weight at Barclays
14d ago
IONS
Cautious Optimism for Ionis Pharmaceuticals: Hold Rating Amid Awaited Olezarsen Data
PremiumRatings
Cautious Optimism for Ionis Pharmaceuticals: Hold Rating Amid Awaited Olezarsen Data
14d ago
IONS
Promising Drug Pipeline and Positive Study Outlook Justify Buy Rating for Ionis Pharmaceuticals
PremiumRatings
Promising Drug Pipeline and Positive Study Outlook Justify Buy Rating for Ionis Pharmaceuticals
18d ago
IONS
Ionis Pharmaceuticals partner Biogen announces results from salanersen study
PremiumThe Fly
Ionis Pharmaceuticals partner Biogen announces results from salanersen study
19d ago
BIIB
IONS
Ionis announces Geary to retire as Chief Development Officer
PremiumThe FlyIonis announces Geary to retire as Chief Development Officer
1M ago
IONS
Ionis Pharmaceuticals Announces Leadership Transition
Premium
Company Announcements
Ionis Pharmaceuticals Announces Leadership Transition
1M ago
8K
IONS
Ionis Pharmaceuticals price target raised to $48 from $45 at JPMorgan
Premium
The Fly
Ionis Pharmaceuticals price target raised to $48 from $45 at JPMorgan
1M ago
IONS
Ionis Pharmaceuticals doses first patient in REVEAL study
PremiumThe Fly
Ionis Pharmaceuticals doses first patient in REVEAL study
1M ago
IONS
Ionis Pharmaceuticals Holds Annual Stockholders Meeting
PremiumCompany Announcements
Ionis Pharmaceuticals Holds Annual Stockholders Meeting
1M ago
8K
IONS
Ionis Pharmaceuticals: Buy Rating Affirmed Amid Promising Clinical Trial Results and Future Prospects
PremiumRatings
Ionis Pharmaceuticals: Buy Rating Affirmed Amid Promising Clinical Trial Results and Future Prospects
2M ago
IONS
Cautious Optimism for Ionis Pharmaceuticals Amid Promising Olezarsen Data and Awaited CORE/CORE2 Insights
PremiumRatings
Cautious Optimism for Ionis Pharmaceuticals Amid Promising Olezarsen Data and Awaited CORE/CORE2 Insights
2M ago
IONS
Promising Phase 3 Results and Future Prospects of Tryngolza Drive Buy Rating for Ionis Pharmaceuticals
PremiumRatingsPromising Phase 3 Results and Future Prospects of Tryngolza Drive Buy Rating for Ionis Pharmaceuticals
2M ago
IONS
Ionis Pharmaceuticals’ Promising Future: Buy Rating Backed by Positive Phase 3 Study Results and Upcoming Milestones
Premium
Ratings
Ionis Pharmaceuticals’ Promising Future: Buy Rating Backed by Positive Phase 3 Study Results and Upcoming Milestones
2M ago
IONS
Promising Clinical Trial Results and Market Potential Justify Buy Rating for Ionis Pharmaceuticals
Premium
Ratings
Promising Clinical Trial Results and Market Potential Justify Buy Rating for Ionis Pharmaceuticals
2M ago
IONS
Ionis Pharmaceuticals: Hold Rating Amid Promising Yet Preliminary Clinical Trial Results
PremiumRatings
Ionis Pharmaceuticals: Hold Rating Amid Promising Yet Preliminary Clinical Trial Results
2M ago
IONS
Ionis Pharmaceuticals Announces Positive Essence Study Results
PremiumCompany Announcements
Ionis Pharmaceuticals Announces Positive Essence Study Results
2M ago
8K
IONS
Ionis Pharmaceuticals announces topline results from Essence study of olezarsen
PremiumThe Fly
Ionis Pharmaceuticals announces topline results from Essence study of olezarsen
2M ago
IONS
Ionis Pharmaceuticals: Strong Financial Performance and Promising Pipeline Justify Buy Rating
PremiumRatings
Ionis Pharmaceuticals: Strong Financial Performance and Promising Pipeline Justify Buy Rating
2M ago
IONS
Ionis Pharmaceuticals price target raised to $50 from $45 at H.C. Wainwright
PremiumThe FlyIonis Pharmaceuticals price target raised to $50 from $45 at H.C. Wainwright
2M ago
IONS
Ionis Pharmaceuticals: Strong Buy Rating Backed by Robust Drug Performance and Strategic Market Expansion
Premium
Ratings
Ionis Pharmaceuticals: Strong Buy Rating Backed by Robust Drug Performance and Strategic Market Expansion
2M ago
IONS
Ionis Pharmaceuticals price target lowered to $64 from $65 at Guggenheim
Premium
The Fly
Ionis Pharmaceuticals price target lowered to $64 from $65 at Guggenheim
2M ago
IONS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >